Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aswath P Chandrasekar

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Transfusion Medicine Reviews|November 26, 2025
The Science Behind Clinical Practice: What is a CAR-T Cell?Aswath P Chandrasekar
Frontiers in Immunology|November 7, 2022
Prime, shock and kill: BCL-2 inhibition for HIV cureAswath P Chandrasekar, Andrew D Badley
Clinical Chemistry|March 2, 2024
"It's Pink!"Aswath P Chandrasekar, Qian Wang, Darci R Block
Oncotarget|April 19, 2021
The long road to TRAIL therapy: a TRAILshort detourAswath P Chandrasekar, Mark Maynes, Andrew D Badley
Frontiers in Cellular and Infection Microbiology|March 20, 2024
Dynamic modulation of the non-canonical NF-κB signaling pathway for HIV shock and killAswath P Chandrasekar, Mark Maynes, Andrew D Badley
Clinical Microbiology Reviews|November 1, 2019
The Role of the BCL-2 Family of Proteins in HIV-1 Pathogenesis and PersistenceAswath P Chandrasekar, Nathan W Cummins, Andrew D Badley
Case Reports in Hematology|October 17, 2025
Improved Preprocedure Hematocrit in Chronic RBC Exchange Patients Following Splenectomy: A Case ReportAswath P Chandrasekar, Scott A Koepsell, Shelly M Williams, et al.
Journal of Virology|November 30, 2022
The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse ModelAswath P Chandrasekar, Nathan W Cummins, Sekar Natesampillai, et al.
Transfusion|February 17, 2025
Increasing use of CAR-T therapy occurs in conjunction with decreasing stem cell transplants with stable resource usage over a 6-year period: Resource utilization implicationsAswath P Chandrasekar, Margret A DiGuardo, Jeffrey L Winters, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 14, 2019
TRAILshort Protects against CD4 T Cell Death during Acute HIV InfectionSekar Natesampillai, Ana C Paim, Nathan W Cummins, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Transfusion Medicine Reviews|November 26, 2025
The Science Behind Clinical Practice: What is a CAR-T Cell?Aswath P Chandrasekar
Frontiers in Immunology|November 7, 2022
Prime, shock and kill: BCL-2 inhibition for HIV cureAswath P Chandrasekar, Andrew D Badley
Clinical Chemistry|March 2, 2024
"It's Pink!"Aswath P Chandrasekar, Qian Wang, Darci R Block
Oncotarget|April 19, 2021
The long road to TRAIL therapy: a TRAILshort detourAswath P Chandrasekar, Mark Maynes, Andrew D Badley
Frontiers in Cellular and Infection Microbiology|March 20, 2024
Dynamic modulation of the non-canonical NF-κB signaling pathway for HIV shock and killAswath P Chandrasekar, Mark Maynes, Andrew D Badley
Clinical Microbiology Reviews|November 1, 2019
The Role of the BCL-2 Family of Proteins in HIV-1 Pathogenesis and PersistenceAswath P Chandrasekar, Nathan W Cummins, Andrew D Badley
Case Reports in Hematology|October 17, 2025
Improved Preprocedure Hematocrit in Chronic RBC Exchange Patients Following Splenectomy: A Case ReportAswath P Chandrasekar, Scott A Koepsell, Shelly M Williams, et al.
Journal of Virology|November 30, 2022
The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse ModelAswath P Chandrasekar, Nathan W Cummins, Sekar Natesampillai, et al.
Transfusion|February 17, 2025
Increasing use of CAR-T therapy occurs in conjunction with decreasing stem cell transplants with stable resource usage over a 6-year period: Resource utilization implicationsAswath P Chandrasekar, Margret A DiGuardo, Jeffrey L Winters, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 14, 2019
TRAILshort Protects against CD4 T Cell Death during Acute HIV InfectionSekar Natesampillai, Ana C Paim, Nathan W Cummins, et al.
Pageof 2